vimarsana.com

Page 31 - மீஜுஹோ பத்திரங்கள் ஒன்றுபட்டது மாநிலங்களில் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biopharma Hopes to Keep Generalist Investor Attention in 2021

Can the biopharma sector retain the investing momentum it saw in 2020 as generalists turned their attention to the space? After a monumental year for biopharma investment in 2020, how much of that momentum can the sector carry over into the new year? Market watchers are beginning to place their bets.  This year, the annual Biotech Showcase event went digital in the face of the global COVID-19 pandemic, with experts in the space meeting online to share the latest insider information with investors. One immediately recognizable trend was how much of a push the biopharma industry has experienced thanks to a growing appetite from generalist investors. This was in large part due to the attention that drug development received last year it led to a rush of initial public offerings (IPOs) and to the emergence of special purpose acquisition companies (SPACs) in the space.

American Tower in €7 7B Telxius deal; Monmouth to study strategic alternatives

Corporate America Not Likely To Unwind COVID-19 Debt Buildup Despite Credit Hits Blog Blog Six trends shaping the industries and sectors we cover in 2021 15 Jan, 2021 Author Saadoon MinhasJake Mooney S&P Global Market Intelligence offers our top picks of real estate news stories and more published throughout the week. After an uninspiring year for real estate investment trust stocks in 2020, analysts took divergent views on the outlook for the sector in the coming year. Analysts at Mizuho Securities USA, Janney Montgomery Scott and Jefferies all noted in forecasts that generalist and retail investors turned cool on REITs in 2020, seeing more attractive growth in other industries. The teams differed in their views of 2021, though, based in part on their expectations for interest rate movement.

Greenberg Traurig s Alan Annex Leads Over $25 Billion in SPAC Transactions in 2020

Greenberg Traurig’s Alan Annex Leads Over $25 Billion in SPAC Transactions in 2020 Share Article Over the past year, Alan I. Annex, co-chair of Greenberg Traurig, P.A.’s Global Corporate Practice, has led numerous multi-disciplinary teams of attorneys assisting clients involved in more than $25 billion in Special Purpose Acquisition Company (SPAC) transactions, both nationally and internationally. MIAMI, FL (PRWEB) January 06, 2021 Over the past year, Alan I. Annex, co-chair of Greenberg Traurig, P.A.’s Global Corporate Practice, has led numerous multi-disciplinary teams of attorneys assisting clients involved in more than $25 billion in Special Purpose Acquisition Company (SPAC) transactions, both nationally and internationally. These transactions, which include both Initial Public Offerings (IPOs) and business combinations, show no signs of slowing in 2021.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.